Free Respiratory Evaluation and Smoke-exposure reduction by primary Health cAre Integrated gRoups (FRESH AIR)
A team of researchers from Plymouth University have been collaborating with international researchers to develop a study which address the problem of chronic lung disease in resource-poor settings. They are working alongside the International Primary care Respiratory Group and in 2015 have established an International Lung Consortium in Kampala and a new Lung Institute within Makerere University.
The overall aim of the FRESH AIR consortium and this project is to improve health outcomes for people at risk of or suffering from non-communicable lung diseases in low-resource settings.
- To identify the specific factors that influence the implementation of evidenced-based interventions in the prevention and treatment of non-communicable lung diseases in community settings in four countries representing very different contexts: the Kyrgyz Republic, Vietnam, Uganda and Greece. (WP3)
- To explore which awareness-raising approaches are most effective in motivating behaviour change in tobacco consumption and HAP exposure and to evaluate the feasibility, acceptability and effectiveness of HAP reduction interventions in selected communities in these countries. (WP4)
- To provide access to smoking cessation support by adapting successful evidence-based Very Brief Advice (VBA) interventions that will be delivered by healthcare workers in these countries. (WP5)
- To test the feasibility and acceptability of methods for diagnosing COPD using innovative spirometry. (WP5)
- To test the feasibility and acceptability of pulmonary rehabilitation (PR) as a low-cost treatment for obstructive lung disease. (WP5)
- To test how to best reduce children’s respiratory symptoms and the risk of lung damage by exploring interventions designed to raise awareness of the damaging effects of exposure to tobacco smoke and HAP during pregnancy and infancy and to improve diagnosis and treatment of children aged under-5 presenting to primary care with respiratory symptoms. (WP6)
- To generate new knowledge, innovation and scalable models that ensure equitable access and to support their implementation through proactive dissemination within the four countries, regionally and internationally. (WP3 to WP7)